Walgreens expands prescription delivery program nationwide
The move by Walgreens reflects the brick-and-mortar store chain's efforts to compete against Amazon.com.
Infant ibuprofen recalled from Walmart, CVS, Family Dollar stores
Tris Pharma recalled several lots after finding that it may contain a higher concentration of ibuprofen.
Major recall of infant ibuprofen sold at Walmart, CVS, Family Dollar
Infant ibuprofen recall
Amazon workers treated after bear repellent releases fumes
Authorities say 24 workers at an Amazon warehouse in New Jersey have been taken hospitals for treatment after bear repellant fell off a shelf and released fumes, including one person who is in critical condition.
Google's robotic spinoff launches ride-hailing service
Google's self-driving car spinoff is finally ready to try to profit from its nearly decade-old technology.
CVS offers 'guaranteed net cost' for pharmacy benefit clients
The new plan model is aimed at providing greater drug cost simplicity, predictability and transparency, CVS said.
Elm Pet Foods, others recall dog food over vitamin D
Elm Pet Foods is the latest maker of dog food to issue a recall over elevated levels of vitamin D, which can cause kidney failure at high enough levels.
More US beef being recalled over salmonella fears
More U.S. beef is being recalled because it may be contaminated with salmonella.
Here's how much the flu season could cost this year
“If the flu season continues to be as severe as the 2009 swine flu pandemic, productivity losses could hit $21 billion,” a report found.
Tribune Media, Amazon rise; GlaxoSmithKline, Discovery fall
Stocks that moved substantially or traded heavily Monday: Tribune Media Co., up $4.72 to $44.98 The TV station owner agreed to be acquired by Nexstar, four months after a bid from Sinclair Broadcast Group collapsed.
Can better cancer care lower company's health costs?
Cancer is one of the most expensive conditions to treat, driving about 20 percent of a company's healthcare spend.
GlaxoSmithKline to spend $5.1B on cancer drugmaker Tesaro
Shares of Tesaro soared early Monday after GlaxoSmithKline said it would pay about $5.1 billion in cash to buy the cancer drugmaker.
GlaxoSmithKline to spend $5.1B on cancer drugmaker Tesaro
Glaxo plans to pay $75 per share for Tesaro.
Stocks climb as investors hope for Trump-Xi trade progress
Stocks are wobbling ahead of the highly-anticipating trade meeting between President Donald Trump and President Xi Jinping of China.
Repeat outbreaks pressure produce industry to step up safety
After repeated food poisoning outbreaks linked to romaine lettuce, the produce industry is confronting the failure of its own safety measures in preventing contaminations.
US life expectancy drops
The factors leading to a drop in U.S. life expectancy
German pharmaceutical company Bayer cutting 12,000 jobs
German pharmaceutical giant Bayer AG says it's cutting 12,000 jobs worldwide as it seeks to reduce costs.
FDA permits 'export only' medical devices not for use in US
Australian Army veteran Wolfgang Neszpor was stunned when he heard his recently repaired shoulder squeak.
CVS, Aetna merger: What it means for you
The $69 billion mega-merger was finalized on Wednesday.
CVS, Aetna finalize $69B merger
CVS expects the deal to save as much as $750 million over the course of two years.














